New cutting edge drug cuts risk of breast cancer tumours reoccurring or spreading by 37%
The ground-breaking drug, Keytruda also known as Pembrolizumab has been found to cut the risk of triple-negative breast cancer reoccurring by 37%. The drug utilizes the patient’s own immune system to fight cancer. Pembrolizumab helps the immune system to be on the alert for cancer cells and destroy them. It is already being used to … Read more
